Notification of major interest in shares Mediclinic International plc (Incorporated in England and Wales) Company Number 8338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 2 March 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are Mediclinic International plc attached: 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights x An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights Other (please specify): 3. Full name of person(s) subject to the notification obligation: Coronation Asset Management (Pty) Ltd 4. Full name of shareholder(s) (if different from 3.): N/A 5. Date of the transaction and date on which the threshold is crossed or 02 March 2017 reached: 6. Date on which issuer notified: 02 March 2017 7. Threshold(s) that is/are crossed or reached: 4% 8. Notified details: A: Voting rights attached to shares Class/type of Situation previous Resulting situation after the triggering transaction shares to the triggering transaction if possible using Number Number Number Number of voting % of voting rights the ISIN CODE of of of shares rights Shares Voting Rights Direct Direct Indirect Direct Indirect GB00B8HX8Z88 28 950 889 28 950 889 29 778 806 29 778 806 4.03% B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion Period rights that may be rights acquired if the instrument is exercised/ converted. C: Financial Instruments with similar economic effect to Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial Exercise Expiration Exercise/ Number of voting rights % of voting rights instrument price date Conversion instrument refers to period Nominal Delta Total (A+B+C) Number of voting rights Percentage of voting rights 29 778 806 4.03% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: Proxy Voting: 10. Name of the proxy holder: Coronation Asset Management (Pty) Ltd 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: 14. Contact name: Jamie Rowland 15. Contact telephone number: +27 21 680 2000 Mediclinic’s primary listing is on the Main Market of the LSE, with secondary listings on the JSE in South Africa and on the NSX in Namibia. Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom Website: www.mediclinic.com Corporate broker: Morgan Stanley & Co International plc JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited) NSX sponsor: Simonis Storm Securities (Pty) Ltd For further information please contact: Mediclinic International plc James Arnold, Head of Investor Relations ir@mediclinic.com Capita Company Secretarial Services Limited Victoria Dalby +44 (0)207 954 9600 Date: 02/03/2017 02:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.